|
LN-145-S1 Clinical Trials
1 actively recruiting trial across 1 location
Also known as: TIL, autologous tumor infiltrating lymphocytes
La Jolla, California1 trial
Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors
University of California, San Diego
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.